home All News open_in_new Full Article

Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance

ATLANTA, April 11, 2025 (GLOBE NEWSWIRE) — Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on developing new medicines to treat pain and fatigue-related disorders, today announced that it has received written confirmation from Nasdaq that it has regained compliance with Nasdaq Listing Rule 5550(b)(1), which requires minimum stockholders’ equity of […]


today 3 d. ago attach_file Economics

attach_file Economics
attach_file Other
attach_file Economics
attach_file Sport
attach_file Events
attach_file Economics
attach_file Events
attach_file Events
attach_file Science
attach_file Other
attach_file Economics
attach_file Economics
attach_file Society
attach_file Culture
attach_file Economics
attach_file Sport
attach_file Economics
attach_file Economics
attach_file Economics
attach_file Politics


ID: 1831184527
Add Watch Country

arrow_drop_down